A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7049389 in Healthy Volunteers and Chronic Hepatitis B Virus (HBV) Infected Participants
Clinical trial NCT02952924 · COMPLETED
Trial details
- NCT number
- NCT02952924
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-14
- Primary completion
- 2022-03-16
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.